CVS Health Corp.
CVS | NYSE
$90.24
-$0.09 (-0.10%)
At close: Oct 30, 2026, 3:59 PM ET
$90.33
+$0.09 (+0.10%)
Pre-market:
Nov 2, 2026, 4:41 AM ET
Company Profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Key Executives
| Name | Position |
|---|---|
| J. David Joyner CEBS | CEO, President & Chairman |
| Brian O. Newman | Executive Vice President & Chief Financial Officer |
| Heidi Capozzi | Executive Vice President & Chief People Officer |
| Samrat S. Khichi | Executive VP of Corporate Affairs & Chief Legal Officer |
| David A. Falkowski | Executive Vice President & Chief Compliance Officer |
| Gustavo A. Giraldo | Head of Markets of Healthcare Benefits |
| James David Clark | Senior Vice President, Controller & Chief Accounting Officer |
| Kristina V. Fink | Senior VP, Chief Governance Officer & Corporate Secretary |
| Prem S. Shah | Executive Vice President & Group President |
| Steven Hale Nelson | Executive Vice President & President of Aetna |
| Tilak Mandadi | EVice President of Ventures and Chief Experience & Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 17, 2026 | 8-K | Current Report |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 06, 2026 | 13F-HR | Quarterly report filed by institutional managers, ... |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Jun 29, 2026 | 4 | Filing |
| Jun 23, 2026 | 11-K | Filing |
| Jun 01, 2026 | 4 | Filing |
| Jun 01, 2026 | 4 | Filing |
| May 22, 2026 | 4 | Filing |
CVS Health Corp.
| Country | United States |
| IPO Date | Feb 21, 1973 |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Employees | 259,500 |
| CEO | J. David Joyner |
Contact Details
One CVS Drive Woonsocket,
Rhode Island 02895 United States
Stock Details
| Ticker Symbol | CVS |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000064803 |
| CUSIP Number | 126650100 |
| ISIN Number | US1266501006 |
| SIC Code | 5912 |
Recent News
- 1 day ago / 247wallst.comAfter He Returned From The Pacific Theater, A World War II Vet Bought $1,000 Of Walgreen Stock. 7 Decades Later, Russ Gremel’s $1,000 Investment Had Grown To Over $2 Million
- 3 days ago / zacks.comCountdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
- 4 days ago / seekingalpha.comCVS Q3 Preview: Accelerating Growth, Near 3% Yield, Meaningful Upside Long-Term
- 4 days ago / zacks.comBrokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
- 5 days ago / zacks.comCVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
- 5 days ago / prnewswire.comDid CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
- 6 days ago / businesswire.comCVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
- 6 days ago / fool.comShould You Buy CVS Health Stock While It's Under $100?
- 7 days ago / zacks.comCVS Health Q3 Earnings Preview: How to Approach the Stock?
- 10 days ago / zacks.comIs Trending Stock CVS Health Corporation (CVS) a Buy Now?
Add to Watchlist
Select watchlists to add or remove CVS